+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1



Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1



Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174




(PDF emailed within 1 workday: $29.90)

Accession: 029526982

Download citation: RISBibTeXText


Related references

Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. Journal of General Virology 70: 2587-2594, 1989

Effect of immunization on the development of a latent ganglionic infection in mice challenged intra vaginally with herpes simplex virus type 1 and herpes simplex virus type 2. Abstracts of the Annual Meeting of the American Society for Microbiology 77: 331, 1977

Investigation of the virulence genes of herpes simplex virus type 2 by experimental infection in vivo with defined intertypic recombinants of a virulent herpes simplex virus type 2x an avirulent herpes simplex virus type. Medical Microbiology & Immunology 174(5): 237-248, 1985

Physical mapping of herpes simplex virus coded functions and poly peptides by marker rescue and analysis of herpes simplex virus type 1 herpes simplex virus type 2 inter typic recombinants. De-The, G , W Henle And F Rapp (Ed ) Iarc (International Agency For Research on Cancer) Science Publications, No 24 Oncogenesis And Herpesviruses, Iii Part 1: Dna Of Herpesviruses, Viral Antigens, Cell-Virus Interaction; Proceedings Of The 3rd International Symposium, Cambridge, Mass , Usa, July 25-29, 1977 Lv+580p International Agency For Research on Cancer: Lyon, France Illus P11-32, 1978, 1979

Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proceedings of the National Academy of Sciences of the United States of America 84(16): 5908-5912, 1987

Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228(4700): 737-740, 1985

Protection of mice against lethal herpes simplex virus type 1 infection by herpes simplex virus type 1 primed spleen cells re stimulated in vitro. Federation Proceedings 41(3): ABSTRACT 1758, 1982

Subcutaneous immunization with purified herpes simplex virus glycoprotein d protects against keratitis and latency following corneal challenge with herpes simplex virus type 1. Investigative Ophthalmology & Visual Science 27(3 SUPPL): 114, 1986

Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice. Infection and Immunity 16(2): 717-719, 1977

Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Investigative Ophthalmology & Visual Science 34(8): 2460-2468, 1993

Mapping of a herpes simplex virus type 2 encoded function that affects the susceptibility of herpes simplex virus infected target cells to lysis by herpes simplex virus specific cyto toxic t lymphocytes. Journal of Virology 49(3): 766-771, 1984

Immunization of mice with a vaccinia recombinant virus which expresses the glycoprotein b gene of herpes simplex virus type 1. Lasky, L (Ed ) Ucla (University Of California-Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 84 Technological Advances in Vaccine Development; Genentech, Ortho, Smith Kline And French-Ucla Symposium, Park City, Utah, Usa, January 30-February 6, Xxviii+691p Alan R Liss, Inc : New York, New York, Usa Illus 215-222, 1988

Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2. Frontiers in Microbiology 3: 158, 2012

Comparison of recombinant herpes simplex virus type 2 specific glycoprotein g with herpes simplex virus for the detection of herpes simplex type 2 specific antibodies. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 349, 1990

Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations. Investigative Ophthalmology & Visual Science 38(6): 1213-1221, 1997